Conditions: Tonsillectomy Tonsillitis Post-operative Pain
Keywords: Liposomal Bupivacaine
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 39
Healthy volunteers: yes

Brief summary:
The purpose of this study is to determine whether liposomal bupivacaine (long acting injectable anesthetic) provides greater post operative pain relief compared to the standard post operative pain regiment for tonsillectomy patients.

Detailed description:
Subjects will be screened in the clinic when being evaluated for indications for tonsillectomy. Once the decision to proceed with tonsillectomy is made, the patient will be given the information on the study, provided time to review the information and interested patients will be consented.

There will be two stages in the study. The first will be the operative stage, which includes the injection during the operation. The second stage is the patient participation stage. During this stage, the patient records the amount of oral pain medication usage, oral intake after their procedure, in addition to their pain scores. These scores are recorded and brought back (or mailed in) to the clinic for collection during the follow up visit, approximately 1 month later (patients will keep records for two weeks). The patients will be freed from participation in the study after the one month visit.

Arms:
arm 1: Patient will receive liposomal bupivacaine in the tonsillar fossae after tonsillectomy arm 2: Patient will not be given any medications in the tonsillar fossae after tonsillectomy

Interventions: intervention 1: Liposomal Bupivacaine
Intervention descriptions: intervention 1: Injection of 8 ml of liposomal bupivacaine total in the tonsillar fossae after tonsillectomy.

Protocol document: